DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK 26.03.2025, 07:00 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
DKSH Holding 61,25 EUR +0,66 % L&S Exchange

DKSH Management Ltd. / Key word(s): Takeover
DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK

26.03.2025 / 07:00 CET/CEST


Media release

DKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”), a well- established player in the South-Korean life-science space. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Zurich, Switzerland, March 26, 2025 – DKSH has announced today that it signed an agreement to acquire MDxK, a well-established South Korean provider of advanced scientific solutions. MDxK specializes in providing state-of-the-art solutions for molecular diagnostics, cellular analysis, structural biology, and biobanking. The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market, further complementing its scientific workflow solutions and solidifying its position in the life science sector in South Korea.

MDxK was established in 2007 and is based in Seoul, South Korea. The company builds on trusted relationships with renowned clients from the global life science industry. With a strong focus on molecular diagnostics and research, MDxK serves a wide range of customers, including hospitals, research institutes, laboratories, universities, pharma and food & beverage companies. MDxK employs around 25 people and generates annual net sales of ca. CHF 10 million1 at good profitability.  

Hanno Elbraechter, Head Business Unit Technology at DKSH, said: “MDxK is a successful, deeply rooted scientific solutions provider that complements our offering very well. Based on trends like rising health needs and the growing emphasis on research and development, we expect demand for advanced scientific solutions in South Korea to significantly increase in the coming years. We are excited to collectively leverage MDxK’s existing business and to benefit from the synergies created by this step.”

Sungbo Shim, Owner and Managing Director of MDxK, commented: “We are delighted to see our company join DKSH, as this step represents another milestone in our nearly 20-year legacy and is part of our strategic leadership transition. We are confident our longstanding business partners, as well as our valued employees, will benefit from this step. We look forward to further growing our business, as we benefit from DKSH’s existing sales channels and networks across the market.”

The closing of the transaction is expected during the second quarter of 2025 and is subject to certain conditions.

1 Exchange rate 1 Swiss Franc / 1’600 KRW

About DKSH 
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec 

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Melanie Grüter
Manager Group Media Relations
Phone +41 44 386 7211
melanie.grueter@dksh.com



End of Media Release


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 2106364

 
End of News EQS News Service

2106364  26.03.2025 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer